stockrowLakefront Biotherapeutics - Sponsored ADR (LKFT) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Lakefront Biotherapeutics - Sponsored ADR LKFT 33.37 −0.57%
- Recursion Pharmaceuticals, Inc. RXRX 3.52 +0.57%
Lakefront Biotherapeutics - Sponsored ADR and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.2B). Recursion Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 56.2% against −52.2%. Lakefront Biotherapeutics - Sponsored ADR has the higher net margin (−6.81% vs −697.1%) and the higher return on invested capital (0.00% vs −88.5%). Across the 18 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 14 and Recursion Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | LKFT | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 89.75% | 29.21% | 68.51% |
| Operating margin | (90.11%) | (725.44%) | 0.00% |
| Net margin | (6.81%) | (697.13%) | 0.00% |
| Free cash flow margin | 0.00% | (460.89%) | 0.00% |
| Return on equity | 0.00% | (48.72%) | (51.96%) |
| Return on assets | 0.00% | (36.29%) | (46.06%) |
| Return on invested capital | 0.00% | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack